|
FBIO | Fortress Biotech, Inc. |
|
|
FBIO | Fortress Biotech, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ -0.60 |
| Leverage | 110.02% |
| Market Cap | $ 21.2m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -48.2m |
| Margin | -75.82% |
Fortress Biotech, Inc., a biopharmaceutical company, develops and markets pharmaceutical and biotech products. The company is headquartered in New York, New York.